Forskolin: Difference between revisions
Jump to navigation
Jump to search
imported>Kevin No edit summary |
imported>Kevin No edit summary |
||
| Line 21: | Line 21: | ||
==References== | ==References== | ||
*[https://pubchem.ncbi.nlm.nih.gov/compound/47936 PubChem] | |||
*[http://www.xenbase.org/literature/article.do?method=display&articleId=11986 Kim et al., 1999] | *[http://www.xenbase.org/literature/article.do?method=display&articleId=11986 Kim et al., 1999] | ||
>786 Xenbase articles contain a reference to Forskolin according to [http://www.xenbase.org/cgi-bin/textpresso/xenopus/search textpresso] | >786 Xenbase articles contain a reference to Forskolin according to [http://www.xenbase.org/cgi-bin/textpresso/xenopus/search textpresso] | ||
*[[Small Molecules for Xenopus Research|Back To Small Molecules Home Page]] | *[[Small Molecules for Xenopus Research|Back To Small Molecules Home Page]] | ||
Revision as of 12:45, 2 June 2015
Description
Activator of adenylyl cyclase.
Marketed as a dietary supplement/alternative medication.
"Cell-permeable diterpenoid that possesses anti-hypertensive, positive inotropic, and adenylyl cyclase activating properties. Many of its biological effects are due to its activation of adenylyl cyclase and the resulting increase in intracellular cAMP concentration.1 Forskolin effects calcium currents and inhibits MAP kinase."
- -Sigma product description
Genes Affected
Suppliers
Usage Notes
50uM
References
>786 Xenbase articles contain a reference to Forskolin according to textpresso